CN1051019C - 逐瘀通脉胶囊 - Google Patents

逐瘀通脉胶囊 Download PDF

Info

Publication number
CN1051019C
CN1051019C CN97115789A CN97115789A CN1051019C CN 1051019 C CN1051019 C CN 1051019C CN 97115789 A CN97115789 A CN 97115789A CN 97115789 A CN97115789 A CN 97115789A CN 1051019 C CN1051019 C CN 1051019C
Authority
CN
China
Prior art keywords
present
radix
capsule
rhizoma rhei
fine powder
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CN97115789A
Other languages
English (en)
Other versions
CN1211433A (zh
Inventor
杨秋艳
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
HARBIN PHARMACEUTICAL GROUP SANJING QIANHE PHARMACEUTICAL CO Ltd
Original Assignee
HEGANG SHENG'ER PHARMACEUTICAL INDUSTRY Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by HEGANG SHENG'ER PHARMACEUTICAL INDUSTRY Co Ltd filed Critical HEGANG SHENG'ER PHARMACEUTICAL INDUSTRY Co Ltd
Priority to CN97115789A priority Critical patent/CN1051019C/zh
Publication of CN1211433A publication Critical patent/CN1211433A/zh
Application granted granted Critical
Publication of CN1051019C publication Critical patent/CN1051019C/zh
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

本发明提出的纯中药制剂逐阏通脉胶囊能有效地治疗由高粘滞血症引起的各种心脑血管类疾病。其特征是以中药水蛭、虻虫、桃仁、大黄为主要配方,将大黄粉碎备用,其余三味药加水煎煮、浓缩成浸膏,加入大黄粉混匀,减压干燥,粉碎成细粉,加入适量辅料,混匀,制粒,装入胶囊即得。本发明配方以中医理论为基础,参照古方《抵挡丸》之方义,配制方法科学、合理,疗效十分显著,且能达到标本兼治。

Description

逐瘀通脉胶囊
本发明涉及一种纯中药制剂,尤其是用于治疗由高粘滞血症引起的心脑血管类疾病的中药药方。
目前,对由于血液粘滞度高所致的心脑血管类疾病还没有非常有效的药物加以治疗。以“步长脑心通”和“博洛克”等市场看好的新药为例:前者,主要作用机理是能够抗血小板凝聚,后者主要作用机理是能够降低纤维蛋白原,它们不能同时改善上述两种主要指标。
本发明的目的是要提供一种治疗高粘滞血症引起的心脑血管类疾病的良药逐瘀通脉胶囊,它能同时改善金血还原粘度,纤维蛋白原和血小板聚集等项指标。疗效更加可靠,治疗更加彻底,能达到标本兼治。
本发明是这样实现的:采用下列中药作为本药方的配方。
水蛭、虻虫、桃仁、大黄
以上四味,取大黄粉碎备用,其余三味加水煎煮三次,合并煎液,滤过,滤液浓缩成浸膏,加入大黄细粉,混匀,减压干燥,粉碎成细粉,加入辅料适量,混匀,制粒,装入胶囊即得。药方中水蛭为君,本品逐恶血久瘀,破血散瘀之力最强。臣以虻虫,本品类水蛭,亦是一味峻猛的破血药,二者常相须使用。盖水蛭味成,咸能软坚走血,其性阴潜,而专逐久积之血,虻虫味苦,苦能开泄瘀,其性刚猛,而善攻新之血,二者合用,新久之瘀血一并攻而破之。佐以桃仁破血逐瘀,其性散而不收,泻而无补,而善行表里之瘀血。大黄为使药,经改变剂型后无泻下作用,取其加在血分药中亦是破瘀血之良药。全方四味药皆为破血逐瘀之品,相互配伍,其功益著。
本发明药方以中医理论为基础,参照古方《抵挡丸》之方义,经十余年的反复试验和临床应用,摸索出了最佳疗效的处方,配制方法科学、合理,疗效显著,无毒副作用,技术含量高,质量稳定,与同类产品比较,有不可替代的优势。适用于高粘滞血症引起的脑血栓形成、腔隙性脑梗塞、脑血栓后遗症、脑动脉硬化症、冠心病、心绞痛、心肌梗塞、高血压病、高脂血症、血栓性静脉炎、脉管炎、血管性头痛等病症。主治由高粘滞血症引起的头痛耳鸣、失眠健忘、颈板肢麻、半身不遂、胸闷胸痛、心悸不宁、痛经、舌质紫暗或有瘀斑、脉涩或沉弦等症状。
本发明最佳实施方案如下:
取水蛭500g,虻虫20g,桃仁41.7g,大黄106.7g,以上四味,取大黄粉碎备用,其余三味加水煎煮三次,第一次2小时,第二、三次各1.5小时,合并煎液,滤过,滤液减压浓缩成相对密度为1.32-1.35(50℃测)的浸膏,加入大黄细粉,混匀,减压干燥,粉碎成细粉,加入辅料适量、混匀、制粒、装入胶囊,制成1000粒,即得。还可加工成其他剂型。

Claims (2)

1.一种治疗心脑血管疾病的纯中药制剂逐瘀通脉胶囊,其特征是:
a.原料药物为水蛭、虻虫、桃仁、大黄;
b.取水蛭500g,虻虫20g,桃仁41.7g,大黄106.7g,以上四味,取大黄粉碎备用,其余三味加水煎煮三次,第一次2小时,第二、三次各1.5小时,合并煎液,滤过,滤液减压浓缩成在温度为50℃时相对密度为1.32-1.35的浸膏,加入大黄细粉,混匀,减压干燥,粉碎成细粉,加入辅料适量、混匀、制粒、装入胶囊,制成100O粒,即得。
2.根据权利要求1所述的纯中药制剂逐瘀通脉胶囊,其特征是采用本发明所述原料药物和工艺制得的药粉还可以加工成其他剂型。
CN97115789A 1997-09-18 1997-09-18 逐瘀通脉胶囊 Expired - Lifetime CN1051019C (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN97115789A CN1051019C (zh) 1997-09-18 1997-09-18 逐瘀通脉胶囊

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN97115789A CN1051019C (zh) 1997-09-18 1997-09-18 逐瘀通脉胶囊

Publications (2)

Publication Number Publication Date
CN1211433A CN1211433A (zh) 1999-03-24
CN1051019C true CN1051019C (zh) 2000-04-05

Family

ID=5173446

Family Applications (1)

Application Number Title Priority Date Filing Date
CN97115789A Expired - Lifetime CN1051019C (zh) 1997-09-18 1997-09-18 逐瘀通脉胶囊

Country Status (1)

Country Link
CN (1) CN1051019C (zh)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100374130C (zh) * 2005-12-28 2008-03-12 哈药集团三精千鹤制药有限公司 逐瘀通脉滴丸

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102362905A (zh) * 2011-11-09 2012-02-29 哈药集团三精千鹤制药有限公司 一种逐瘀通脉胶囊的制备方法
CN103505532B (zh) * 2013-10-10 2015-02-25 北京康远制药有限公司 一种具有祛瘀作用的中药颗粒剂及其制备方法

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100374130C (zh) * 2005-12-28 2008-03-12 哈药集团三精千鹤制药有限公司 逐瘀通脉滴丸

Also Published As

Publication number Publication date
CN1211433A (zh) 1999-03-24

Similar Documents

Publication Publication Date Title
CN103202880B (zh) 一种治疗过敏性鼻炎的药物及其制备方法
CN101264154B (zh) 一种中药口服制剂的制备方法
CN1051019C (zh) 逐瘀通脉胶囊
CN1351872A (zh) 一种治疗粉刺痤疮的中药
CN105250427A (zh) 一种治疗心脏疾病的药物组合物
CN104873766A (zh) 一种治疗鼻炎的药物组合物及其制备方法
CN101966261A (zh) 一种治疗高血压的药物及其制备方法
CN101019926A (zh) 一种治疗心脑血管病的中药及其制备方法
CN114246917A (zh) 一种缓解心脑血管疾病生物药剂及生产方法
CN1106291A (zh) 一种藏成药及其制备
CN100415214C (zh) 妇科调经胶囊的制备方法
CN1060663C (zh) 复方藏茵陈成药
CN100522238C (zh) 止痛化癥丸及制备方法
CN100358552C (zh) 一种治疗弱视的药物及其制备方法
CN111743973A (zh) 中药组合物及其制备方法、外用药、应用
CN109350719A (zh) 一种治疗神经性疾病的中药组合物及其制备方法
CN104998019B (zh) 一种活血化瘀,止血止痛的中药组合物
CN105012642B (zh) 一种活血化瘀,止血止痛的中药组合物的制备方法
CN116251152B (zh) 用于生发乌发的中药组合物、中药制剂的制备方法以及应用
CN1044325C (zh) 一种戒毒的药用组合物及其制备方法
CN113769046B (zh) 一种治疗肠化生的中药组合物、制备方法和应用
CN101940779A (zh) 一种补脾益肾的药物组合物的制备方法
CN100455302C (zh) 一种治疗心脑血管注射用丹红冻干粉针剂及制备方法
CN101785792A (zh) 一种中药压榨吸滤提取方法
CN101129706A (zh) 一种治疗动脉硬化的中药制剂

Legal Events

Date Code Title Description
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C06 Publication
PB01 Publication
C14 Grant of patent or utility model
GR01 Patent grant
ASS Succession or assignment of patent right

Owner name: HEGANG JIANGXIANGWEIYE PHARMACEUTICAL CO., LTD.

Free format text: FORMER OWNER: CORRECT DA QINGBHUNNAO ( HEGANG ) PHARMACEUTICAL CO., LTD.

Effective date: 20031107

Owner name: CORRECT DA QINGBHUNNAO ( HEGANG ) PHARMACEUTICAL C

Free format text: FORMER OWNER: HEGANG SHENG'ER PHARMACEUTICAL INDUSTRY CO., LTD.

Effective date: 20031107

C41 Transfer of patent application or patent right or utility model
TR01 Transfer of patent right

Effective date of registration: 20031107

Patentee after: Albert Xiang Hegang Pharmaceutical Co.,Ltd.

Patentee before: Zhengda youth treasure (Hegang) Pharmaceutical Co.,Ltd.

Effective date of registration: 20031107

Address after: 100039 Beijing city Haidian District Xicui Road No. 5 Building No. 10 room 1301 homes today

Patentee after: Zhengda youth treasure (Hegang) Pharmaceutical Co.,Ltd.

Address before: 154108 worker's Farm Road, Hegang, Heilongjiang

Patentee before: HEGANG SHENG ER PHARMACEUTICAL

ASS Succession or assignment of patent right

Owner name: HAYAO GROUP SANJING QIANHE PHARMACEUTICAL CO., LT

Free format text: FORMER OWNER: HEGANG JIANGXIANGWEIYE PHARMACEUTICAL CO., LTD.

Effective date: 20041022

C41 Transfer of patent application or patent right or utility model
TR01 Transfer of patent right

Effective date of registration: 20041022

Address after: Hegang City, Heilongjiang Province, three road 154101 High-tech Industrial Park No. 6

Patentee after: HARBIN PHARMACEUTICAL GROUP SANJING QIANHE PHARMACEUTICAL CO.,LTD.

Address before: 154108 worker's Farm Road, Hegang, Heilongjiang

Patentee before: Albert Xiang Hegang Pharmaceutical Co.,Ltd.

CX01 Expiry of patent term

Granted publication date: 20000405

CX01 Expiry of patent term